Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD22 | P20273 | 5/20 | 0.68 |
| ▸ | SIGLEC7 | Q9Y286 | 1/20 | 0.51 |
| ▸ | MAG | P20916 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16841340 | 0.94 | CD22 (0.69) | CD22 | |
| SCHEMBL16840014 | 0.94 | CD22 (0.65) | CD22 | |
| SCHEMBL18313784 | 0.91 | CD22 (0.65) | CD22MAG | |
| SCHEMBL18083826 | 0.91 | CD22 (0.76) | CD22SIGLEC7 | |
| SCHEMBL18083824 | 0.91 | CD22 (0.76) | CD22SIGLEC7 | |
| SCHEMBL16362515 | 0.90 | CD22 (0.69) | CD22SIGLEC7 | |
| SCHEMBL16373000 | 0.89 | CD22 (0.62) | CD22MAG | |
| SCHEMBL16373105 | 0.89 | CD22 (0.62) | CD22 | |
| SCHEMBL18357220 | 0.89 | CD22 (0.62) | CD22MAG | |
| SCHEMBL16839995 | 0.89 | CD22 (0.62) | CD22MAG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9539336-B2 | Sialic acid derivatives | BROSSMER REINHARD (DE) | 2017-01-10 | — | — | US | disclosed |
| US-9539336-B2 | Sialic acid derivatives | BROSSMER REINHARD (DE) | 2017-01-10 | — | — | US | disclosed |
| US-20150174262-A1 | Sialic Acid Derivatives | BROSSMER REINHARD (DE) | 2015-06-25 | — | — | US | disclosed |
| US-20150174262-A1 | Sialic Acid Derivatives | BROSSMER REINHARD (DE) | 2015-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150174262-A1 | Sialic Acid Derivatives | NEU1, SIGLEC9, SIGLEC7 | CD22 104/4885SIGLEC7 3/4885MAG 700/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.